Clinical Trial Update: Dalteparin Versus Unfractionated Heparin In Patients With Acute Coronary Syndrome [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing dalteparin with unfractionated heparin in acute coronary syndrome was terminated. Results from the study were posted in 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction
• Unstable Angina

Drugs mentioned

• FRAGMIN (DALTEPARIN SODIUM)
• Unfractionated Heparin (unfractionated heparin)

Snippet

Sponsor: Pfizer | Conditions: Angina, Unstable, Myocardial Infarction | Phase 4 | Status: TERMINATED | Results posted: 2010-01-27